4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
CorMedix Inc. (CRMD) operates in the Biotechnology industry and is headquartered in Parsippany, United States with about 191 employees. Its market capitalization is roughly $661 million. In the fiscal year ended 2025-12-31, CRMD reported $312M in revenue and $163M in net income.
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States.
Interactive charts & full statements → Open the CRMD valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total Revenue | $312M | $44M | $0M | $0M |
| Gross Profit | $276M | $40M | $0M | $0M |
| Operating Income (EBIT) | $150M | ($22M) | ($49M) | ($31M) |
| Net Income | $163M | ($18M) | ($46M) | ($30M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $127M | $129M | $104M | $40M | $39M | — |
| Gross Profit | $105M | $107M | $93M | $38M | $38M | — |
| Operating Income (EBIT) | $64M | $59M | $51M | $20M | $20M | — |
| Net Income | $39M | $14M | $109M | $20M | $21M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $826M | $119M | $82M | $62M | — |
| Total Liabilities | $421M | $34M | $12M | $7M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive CRMD viewer.
About TickerBase · Data methodology & sources